WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR September 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: SEPTEMBER ISSUE PUBLISHED

    SEPTEMBER 2026 Issue has been successfully launched on1 SEPTEMBER 2026.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

SUCCESSFUL CONCEPTION IN ENDOMETRIOSIS THROUGH AYURVEDIC INTERVENTION: A CASE STUDY

Dr. Aarati Patil, Dr. Devang Sharma, Dr. Kshitija Berde, Dr. Aishwarya Deshpande*

ABSTRACT

Endometriosis is a chronic inflammatory gynecological disorder characterized by the presence of endometrium-like tissue outside the uterine cavity, leading to pelvic pain, ovarian endometriomas, distorted pelvic anatomy, and infertility.[1] Approximately 30–50% of women with endometriosis experience difficulty conceiving due to impaired ovarian function, altered pelvic environment, inflammation, and reduced endometrial receptivity.[2,3] Conventional management primarily involves hormonal suppression and surgical excision; however, these approaches often fail to address the underlying pathophysiology, may be associated with recurrence, and are not always suitable for women actively attempting conception.[4] Ayurveda approaches endometriosis as a disorder involving vitiation of Vata and Kapha dosha, obstruction of Artava Vaha Srotas, and chronic inflammation affecting reproductive function. Treatment focuses on restoring the normal movement of Apana Vata, reducing pathological tissue growth, improving reproductive health, and enhancing fertility through individualized herbal formulations.[5] This case study presents a 35-year-old woman with bilateral endometriosis presented with primary infertility following a failed intrauterine insemination (IUI) cycle. Baseline transvaginal sonography demonstrated bilateral enlarged ovaries, a 3.0 cm ovarian endometrioma, and a 1.5 cm subserosal fibroid. Her 37-year-old partner had mild male factor infertility characterized by reduced sperm motility (21%) and teratozoospermia (2% normal morphology). The couple underwent five months of individualized Ayurvedic treatment. Follow-up ultrasonography demonstrated a reduction in the endometrioma size from 3.0 cm to 2.5 cm, suggesting improvement in pelvic pathology. Following treatment, the patient conceived naturally, with a positive serum β-human chorionic gonadotropin (β-hCG) test after her last menstrual period dated June 10, 2026.

[Full Text Article] [Download Certificate]